Hyundai Bioscience Income Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Revenue	3,517	15,050	9,481	7,852	9,241
Other Revenue	-	-0	-0	-	-
Revenue	3,517	15,050	9,481	7,852	9,241
Revenue Growth (YoY)	-76.63%	58.73%	20.76%	-15.04%	-26.14%
Cost of Revenue	3,519	3,258	4,490	5,140	6,012
Gross Profit	-1.69	11,792	4,992	2,712	3,229
Selling, General & Admin	9,896	7,598	7,846	6,542	6,647
Research & Development	7,595	3,055	6,401	16,456	4,763
Amortization of Goodwill & Intangibles	-	-	328.42	489.85	1,228
Other Operating Expenses	32.24	38.4	42.25	27.37	61.28
Operating Expenses	18,159	10,959	14,795	29,023	12,519
Operating Income	-18,161	833.79	-9,804	-26,311	-9,289
Interest Expense	-2,435	-2,313	-314.57	-448.65	-3,003
Interest & Investment Income	1,326	210.7	669.19	536.69	291.71
Earnings From Equity Investments	-4,766	-5,730	-	8,834	93.91
Currency Exchange Gain (Loss)	-38.16	3.73	-68.67	48.15	20.39
Other Non Operating Income (Expenses)	1,978	94.13	-335.47	-182.82	-404.46
EBT Excluding Unusual Items	-22,095	-6,901	-9,853	-17,524	-12,291
Gain (Loss) on Sale of Investments	-9.04	14.05	123.67	910.99	-
Asset Writedown	-	-	-4,769	-	-7,517
Pretax Income	-22,105	-6,887	-14,498	-16,613	-19,808
Income Tax Expense	3.89	-	1.04	-805.47	243.5
Earnings From Continuing Operations	-22,108	-6,887	-14,499	-15,807	-20,051
Earnings From Discontinued Operations	-19.95	-42.82	-	-	-
Net Income	-22,128	-6,930	-14,499	-15,807	-20,051
Net Income to Common	-22,128	-6,930	-14,499	-15,807	-20,051
Shares Outstanding (Basic)	105,373	12,832	80	79	74
Shares Outstanding (Diluted)	105,373	12,832	80	79	74
Shares Change (YoY)	721.14%	16030.92%	1.04%	6.64%	2.79%
EPS (Basic)	-0.21	-0.54	-182.26	-200.77	-271.58
EPS (Diluted)	-0.21	-0.54	-182.50	-201.00	-271.58
Free Cash Flow	-18,244	2,087	-6,548	-18,087	-4,285
Free Cash Flow Per Share	-0.17	0.16	-82.31	-229.72	-58.04
Gross Margin	-0.05%	78.35%	52.65%	34.53%	34.95%
Operating Margin	-516.32%	5.54%	-103.40%	-335.10%	-100.52%
Profit Margin	-629.12%	-46.04%	-152.92%	-201.33%	-216.97%
Free Cash Flow Margin	-518.69%	13.87%	-69.06%	-230.36%	-46.37%
EBITDA	-16,855	1,468	-8,369	-24,529	-6,586
EBITDA Margin	-	9.75%	-88.27%	-	-71.27%
D&A For EBITDA	1,306	633.82	1,435	1,782	2,703
EBIT	-18,161	833.79	-9,804	-26,311	-9,289
EBIT Margin	-	5.54%	-103.40%	-	-100.52%
Advertising Expenses	1,546	267.64	996.63	965.59	1,497

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.